Amicus Therapeutics
FOLD
FOLD was delisted on the 24th of April, 2026.
109 hedge funds and large institutions have $662M invested in Amicus Therapeutics in 2014 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 46 increasing their positions, 17 reducing their positions, and 19 closing their positions.
171% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 17
136% more capital invested
Capital invested by funds: $280M → $662M (+$382M)
100% more funds holding in top 10
Funds holding in top 10: 3 → 6 (+3)
84% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 19
15% more funds holding
Funds holding: 95 → 109 (+14)
6% more call options, than puts
Call options by funds: $6.98M | Put options by funds: $6.56M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$31.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$15.9M |
| 3 |
Millennium Management
New York
|
+$14.5M |
| 4 |
State Street
Boston,
Massachusetts
|
+$14.4M |
| 5 |
PA
Perceptive Advisors
New York
|
+$14.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$4.07M |
| 2 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.65M |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$3.4M |
| 4 |
DM
Deerfield Management
New York
|
-$2.86M |
| 5 |
Morgan Stanley
New York
|
-$2.07M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
126
Tower Research Capital (TRC)
New York
| – | -$24K | -4,000 | Closed |
|
127
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$12K | -2,000 | Closed |
|
|
QT
128
Quantbot Technologies
New York
| – | -$8K | -1,444 | Closed |
|
FOLD Hedge Fund Activity: Q4 2014 in Review
109 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q4 2014, worth a combined $662M — up 136% from $280M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new FOLD positions and 19 closed out — a net gain of 16 holders — while 46 added to existing stakes and 17 trimmed.
The largest buyer was Sectoral Asset Management, adding an estimated $31.3M. The largest seller was Visium Asset Management, cutting an estimated $4.07M.
- 109 institutional investors held Amicus Therapeutics (FOLD) as of Q4 2014, up from 95 in Q3 2014.
- Funds reported $662M of Amicus Therapeutics stock for Q4 2014, up 136% quarter-over-quarter.
- 35 funds opened new Amicus Therapeutics positions in Q4 2014 and 19 closed out, a net change of +16 holders.
- The largest Amicus Therapeutics buyer in Q4 2014 was Sectoral Asset Management, an estimated $31.3M added.
- The largest Amicus Therapeutics seller in Q4 2014 was Visium Asset Management, an estimated $4.07M sold.
Based on aggregated 13F filings for Q4 2014.